drugset / Trial / NCT01654185

Dimethyldiguanide Combined With Aromatase Inhibitor (AI) in Metastatic Breast Cancer

NCT01654185

Phase 2 Completed 60 enrolled Xichun Hu
RandomizedParallel-groupOpen-labelTreatment

Summary

The addition of dimethyldiguanide might increase the efficacy of AI treatment in metastatic breast cancer.

Timeline

Start
2012-07
Primary completion
2014-07
Completion
2016-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Dimethyldiguanide Unknown 0.5 unknown
Background Exemestane Small molecule 1 unknown
Background Letrozole Other / unclassified 1 unknown

Indications